Oncology (TOI) | Stock Overview & Key Data
Oncology Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $12.66 on December 27, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Oncology
TOI
|
323.20M Small-cap | 2.17% | 30.15% | 51.91% | 37.40% | 41.14% | 114.98% | 756.45% | -47.43% | -46.04% | -46.04% | -46.04% |
|
HCA Healthcare
HCA
|
106.00B Large-cap | 7.93% | -7.81% | -25.75% | -18.24% | -17.10% | 4.31% | 33.47% | 92.28% | 400.04% | 1,019.34% | 1,144.15% |
|
Tenet Healthcare
THC
|
16.50B Large-cap | 9.88% | -8.92% | -18.33% | -9.23% | -10.20% | 6.26% | 122.70% | 164.92% | 543.08% | 581.20% | 489.27% |
|
Surgery Partners
SGRY
|
1.86B Small-cap | 9.24% | 8.46% | 22.11% | -2.01% | -0.85% | -32.67% | -62.68% | -76.34% | -2.17% | -16.93% | -16.93% |
| 1.91B Small-cap | 8.46% | 8.36% | 25.04% | 7.40% | 14.47% | 73.57% | 75.20% | -20.69% | -64.71% | -31.34% | 9.12% | |
|
Astrana Health
ASTH
|
1.88B Small-cap | -0.03% | 0.31% | 56.02% | 72.11% | 52.18% | 49.98% | 24.10% | -27.77% | 642.69% | 657.25% | 657.25% |
Ownership & Short Interest
Calculate Your Oncology Investment Returns
Long-Term Investment Performance Analysis
Oncology stock price in Jun 2020 was $9.84, A $1,000.00 lump sum investment in Oncology made 6 years ago would be worth approximately $526.42 today, representing a negative return of -47.36%. This translates to an annualized return (CAGR) of -10.08%.
6 Years Investment Scenario (Jun 2020 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is TOI's 52-week high and low?
- In the last 52 weeks, Oncology reached a high of $5.57 (on June 8, 2026) and a low of $2.02 (on June 30, 2025).
- What is the market cap and P/E ratio for TOI?
- Curious about Oncology's size and valuation? Its market capitalization stands at 323.20M. When it comes to valuation, the P/E ratio (trailing twelve months) is N/A, and the forward P/E (looking ahead) is -21.50.
- Does TOI pay dividends? If so, what's the yield?
- As for dividends, Oncology isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Oncology's main competitors or similar companies to consider before investing?
When looking at Oncology, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA106.00B Healthcare Medical Care Facilities 4.31% 33.47% Tenet Healthcare
THC16.50B Healthcare Medical Care Facilities 6.26% 122.70% Surgery Partners
SGRY1.86B Healthcare Medical Care Facilities -32.67% -62.68% Pediatrix Medical
MD1.91B Healthcare Medical Care Facilities 73.57% 75.20% Astrana Health
ASTH1.88B Healthcare Medical Care Facilities 49.98% 24.10% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for The Oncology Institute Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Oncology's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 320.01%, the Debt to Equity ratio from the most recent quarter is -6.60, and its Gross Profit Margin stands at 16.04%.
- What is the recent revenue and earnings growth for TOI?
- Looking at Oncology's growth, its revenue over the trailing twelve months (TTM) was $503M. Compared to the same quarter last year (YoY), quarterly revenue grew by 41.60%, and quarterly earnings saw a YoY growth of 41.58%.
- How much of TOI stock is held by insiders and institutions?
- Wondering who owns Oncology stock? Company insiders (like executives and directors) hold about 20.14% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 45.02%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.